# Herpes Zoster of the Larynx: A Diagnostic and Therapeutic Challenge

**Authors:** Noémi Nogueira, Teresa Bernardo, Simão Bessa, Joana Ferreira, Nuno Lousan

PMC · DOI: 10.7759/cureus.100666 · Cureus · 2026-01-03

## TL;DR

This paper describes a rare case of herpes zoster in the larynx, highlighting the challenges in diagnosis and the importance of early treatment to prevent complications.

## Contribution

The paper presents a rare clinical case of laryngeal herpes zoster and emphasizes the need for early diagnosis and treatment in immunosuppressed patients.

## Key findings

- Herpes zoster of the larynx can present without a typical rash and may mimic other laryngitis causes.
- Early antiviral treatment and endoscopic evaluation are crucial for managing laryngeal herpes zoster.
- Delayed diagnosis can lead to complications like chronic voice impairment and persistent dysphagia.

## Abstract

Herpes zoster of the larynx is an exceptionally rare condition that may mimic more common causes of laryngitis. Reactivation of varicella-zoster virus in the vagus nerve can lead to odynophagia, dysphonia, and dysphagia, often without the typical cutaneous rash. Early recognition is essential, as delayed diagnosis may result in serious complications, including postherpetic neuralgia, persistent dysphagia, chronic voice impairment, and even laryngeal paralysis. We describe a 66-year-old woman on long-term low-dose corticosteroid therapy who presented with acute odynophagia, dysphagia, dysphonia, and fever. Flexible nasopharyngolaryngoscopy revealed supraglottic vesicles localized to the right hemilarynx, extending to the epiglottis and arytenoid region, with ipsilateral sensory loss. Serological testing confirmed varicella-zoster virus infection. The patient was treated with valacyclovir and gabapentin, with resolution of odynophagia and mucosal lesions at one month, though mild dysphagia persisted. Laryngeal herpes zoster represents a diagnostic challenge due to its rarity, overlapping symptoms with other forms of laryngitis, and the brief window of opportunity in which vesicular lesions are visible. The scarcity of reported cases underscores the importance of maintaining a high index of suspicion, particularly in immunosuppressed patients. Early antiviral therapy is crucial to reduce complications, while endoscopic evaluation plays a key role in timely recognition.

## Linked entities

- **Chemicals:** valacyclovir (PubChem CID 135398742), gabapentin (PubChem CID 3446)
- **Diseases:** Herpes zoster (MONDO:0005609), laryngitis (MONDO:0002647), postherpetic neuralgia (MONDO:0041052)

## Full-text entities

- **Diseases:** laryngitis (MESH:D007827), dysphonia (MESH:D055154), postherpetic neuralgia (MESH:D051474), Herpes Zoster (MESH:D006562), voice impairment (MESH:D014832), mucosal lesions (MESH:D009059), fever (MESH:D005334), laryngeal paralysis (MESH:D014826), sensory loss (MESH:C580162), cutaneous rash (MESH:D005076), varicella-zoster virus infection (MESH:D000073618), dysphagia (MESH:D003680), vesicular (MESH:D012872)
- **Chemicals:** gabapentin (MESH:D000077206), valacyclovir (MESH:D000077483)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human alphaherpesvirus 3 (Varicella-zoster virus, no rank) [taxon 10335]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862492/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12862492/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862492/full.md

---
Source: https://tomesphere.com/paper/PMC12862492